These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9054324)

  • 41. Drug susceptibility and its genetic basis in epidemic Vibrio cholerae O1 in Vietnam.
    Ehara M; Nguyen BM; Nguyen DT; Toma C; Higa N; Iwanaga M
    Epidemiol Infect; 2004 Aug; 132(4):595-600. PubMed ID: 15310160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterogeneity in the organization of the CTX genetic element in strains of Vibrio cholerae O139 Bengal isolated from Calcutta, India and Dhaka, Bangladesh and its possible link to the dissimilar incidence of O139 cholera in the two locales.
    Basu A; Mukhopadhyay AK; Sharma C; Jyot J; Gupta N; Ghosh A; Bhattacharya SK; Takeda Y; Faruque AS; Albert MJ; Balakrish Nair G
    Microb Pathog; 1998 Mar; 24(3):175-83. PubMed ID: 9514639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial resistance surveillance of Vibrio cholerae in Thailand from 2000 to 2004.
    Supawat K; Huttayananont S; Sawanpanyalert P; Aswapokee N; Mootsikapun P
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S82-6. PubMed ID: 21294503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibiotic resistance pattern of Vibrio cholerae and Shigella causing diarrhoea outbreaks in the eastern Africa region: 1994-1996.
    Materu SF; Lema OE; Mukunza HM; Adhiambo CG; Carter JY
    East Afr Med J; 1997 Mar; 74(3):193-7. PubMed ID: 9185422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial Drug Resistance of Vibrio cholerae, Democratic Republic of the Congo.
    Miwanda B; Moore S; Muyembe JJ; Nguefack-Tsague G; Kabangwa IK; Ndjakani DY; Mutreja A; Thomson N; Thefenne H; Garnotel E; Tshapenda G; Kakongo DK; Kalambayi G; Piarroux R
    Emerg Infect Dis; 2015 May; 21(5):847-51. PubMed ID: 25897570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial suceptibility of V. cholerae in north west, Ethiopia.
    Abera B; Bezabih B; Dessie A
    Ethiop Med J; 2010 Jan; 48(1):23-8. PubMed ID: 20607994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial susceptibility pattern of Vibrio cholerae O1 strains during two cholera outbreaks in Dar es Salaam, Tanzania.
    Urassa WK; Mhando YB; Mhalu FS; Mjonga SJ
    East Afr Med J; 2000 Jul; 77(7):350-3. PubMed ID: 12862151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The characteristics of Vibrio cholerae isolated in Dagestan in 1994].
    Podosinnikova LS; Mazrukho BL; Lomov IuM; Khanum'ian TA; Voronezhskaia LG; Kudriakova TA; Makedonova LD; Mironova AV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; Suppl 2():74-8. PubMed ID: 7771152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Typing and antibiotic susceptibility patterns of Vibrio cholerae during six consecutive cholera seasons in north India.
    Kaur H; Lal M
    Trop Gastroenterol; 1998; 19(2):59-61. PubMed ID: 9752752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Vibrio cholerae strains resistant to vibriostatic factor 0/129 isolated from a patient with cholera in Poland].
    Stypułkowska-Misiurewicz H; Gardocka H; Sieczka Z
    Med Dosw Mikrobiol; 1994; 46(4):313-21. PubMed ID: 7603133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotypic, genotypic, and antibiotic sensitivity patterns of strains isolated from the cholera epidemic in Zimbabwe.
    Islam MS; Mahmud ZH; Ansaruzzaman M; Faruque SM; Talukder KA; Qadri F; Alam M; Islam S; Bardhan PK; Mazumder RN; Khan AI; Ahmed S; Iqbal A; Chitsatso O; Mudzori J; Patel S; Midzi SM; Charimari L; Endtz HP; Cravioto A
    J Clin Microbiol; 2011 Jun; 49(6):2325-7. PubMed ID: 21471347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Resistance to antibiotics of vibrio cholerae strains isolated in Angola].
    Ferreira E; Costa M; Vaz Pato MV
    Pathol Biol (Paris); 1992 May; 40(5):561-5. PubMed ID: 1495844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasmid profiles and antimicrobial susceptibility patterns of Vibrio cholerae O1 strain isolated during a recent outbreak in Nigeria.
    Olukoya DK; Ogunjimi AA; Abaelu AM
    J Diarrhoeal Dis Res; 1995 Jun; 13(2):118-21. PubMed ID: 7594312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antibiotic susceptibility of Vibrio cholerae 01: evolution after prolonged curative and preventive use during the 2004 cholera epidemics in Douala (Cameroon)].
    Guévart E; Solle J; Mouangue A; Noeske J; Bita A; Fonkoua MC; Ndayo Wouafo M
    Med Mal Infect; 2006 Jun; 36(6):329-34. PubMed ID: 16757139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cholera in Rio Grande do Norte State--Brazil: sorology and sensitivity of Vibrio cholerae to different antimicrobials].
    de Melo LM; Vieira RH; Hofer E; Batista AL; Almeida D
    Acta Cir Bras; 2005; 20 Suppl 1():8-11. PubMed ID: 17768794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Sensitivity of Vibrio and Aeromonas to antibiotics].
    Khaĭtovich AB; Ved'mina EA; Vlasova IV
    Antibiot Khimioter; 1992 Mar; 37(3):10-3. PubMed ID: 1514858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic determinants of virulence, antibiogram and altered biotype among the Vibrio cholerae O1 isolates from different cholera outbreaks in India.
    Goel AK; Jiang SC
    Infect Genet Evol; 2010 Aug; 10(6):815-9. PubMed ID: 19580888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IncA/C plasmids conferring high azithromycin resistance in vibrio cholerae.
    Wang R; Liu H; Zhao X; Li J; Wan K
    Int J Antimicrob Agents; 2018 Jan; 51(1):140-144. PubMed ID: 28919196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tetracycline resistant cholera in Kelantan.
    Ranjit K; Nurahan M
    Med J Malaysia; 2000 Mar; 55(1):143-5. PubMed ID: 11072502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Highly Resistant Cholera Outbreak Strain in Zimbabwe.
    Mashe T; Domman D; Tarupiwa A; Manangazira P; Phiri I; Masunda K; Chonzi P; Njamkepo E; Ramudzulu M; Mtapuri-Zinyowera S; Smith AM; Weill FX
    N Engl J Med; 2020 Aug; 383(7):687-689. PubMed ID: 32786196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.